BIM
ABMD

Bogle Investment Management’s Abiomed Inc ABMD Stock Holding History

Bogle Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-30,143
Closed -$9.8M – 413
2018
Q4 		$9.8M Sell
30,143
-10,666
-26% -$3.71M 0.76% 52
2018
Q3 		$18.4M Sell
40,809
-679
-2% -$268K 1.32% 4
2018
Q2 		$17M Sell
41,488
-6,495
-14% -$2.35M 1.23% 4
2018
Q1 		$14M Buy
+47,983
New +$12.2M 1.05% 11
2015
Q4 		– Sell
-123,312
Closed -$11.4M – 458
2015
Q3 		$11.4M Buy
123,312
+108,771
+748% +$9.58M 0.81% 27
2015
Q2 		$955K Sell
14,541
-190,525
-93% -$12.7M 0.07% 265
2015
Q1 		$14.7M Buy
+205,066
New +$11.1M 1.01% 15

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bogle Investment Management's ABMD Position: Q1 2019 in Review

Bogle Investment Management sold out of Abiomed Inc (ABMD) in Q1 2019, closing a stake of 30,143 shares — an estimated $9.8M sold.

Bogle Investment Management first reported a position in ABMD in Q1 2015 and held it in 7 quarters. The position peaked at $18.4M in Q3 2018. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • Bogle Investment Management reported no remaining Abiomed Inc position as of Q1 2019 after selling out during the quarter.
  • Bogle Investment Management sold 30,143 Abiomed Inc shares in Q1 2019, an estimated $9.8M.
  • Bogle Investment Management first reported a position in Abiomed Inc in Q1 2015 and held it in 7 quarters.
  • Bogle Investment Management's Abiomed Inc position peaked at $18.4M in Q3 2018.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on Bogle Investment Management's 13F filing for Q1 2019, filed 13 May 2019.